DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Pfisterer J, Plante M, Vergote I. et al.
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.
J Clin Oncol 2006;
24: 4699-4707
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.